TATA HEALTH (01255) announces its annual performance in 2023. The company's owners are expected to incur a loss of HKD 322.94 million, a turnaround from profit to loss compared to the previous year.

TATA HEALTH (01255) announced its annual performance for 2023, with revenues of approximately HK$207.5 million, an increase of about 43.5% compared to the previous year. The company's attributable loss amounted to HK$32.294 million, a turnaround from profit to loss, resulting in a loss per share of HK$0.13. The announcement stated that the loss was mainly due to the continued long-term losses and operational stagnation of the healthcare and online medical services business.